Researchers studying a family with a history of early-onset Alzheimer's disease have uncovered a genetic anomaly that delays the onset of symptoms by up to five years. This discovery offers new possibilities for combating the debilitating effects of the disease, provided scientists can decipher how this rare gene variant provides some level of protection.
The breakthrough emerged during a study of a large Colombian family affected by an inherited form of Alzheimer's. One family member, Aliria Piedrahita de Villegas, defied expectations by experiencing cognitive decline in her 70s instead of her 40s, thanks to possessing a unique gene variant known as APOE3 Christchurch.
